HANNAH WILLIAMS: Open Payments
NPI 1770327827 · FRONT ROYAL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 49 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $165 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $321 |
| E.R. Squibb & Sons, L.L.C. | 5 | $176 |
| ABBVIE INC. | 6 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Alkermes, Inc. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Tris Pharma Inc | 1 | $14 |
Products named: UZEDY, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, ABILIFY ASIMTUFII, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
